The role of TSC2 and the mTOR signaling pathway in cancer progression is well-established in humans, and the high frequency of these mutations in chimpanzee samples may indicate a parallel, yet distinct, evolutionary adaptation in this species. This evidence concerns the gene TSC2 and cancer.